Connection

Srinivas Murthy to Pandemics

Back to Details
This is a "connection" page, showing publications Srinivas Murthy has written about Pandemics.
Srinivas Murthy
Connection Strength
0.229
Pandemics
  1. Canada is no global health leader on COVID-19 vaccine equity. Lancet. 2021 05 15; 397(10287):1803.
    View in: PubMed
    Score: 0.032
  2. Clinician-researcher's perspectives on clinical research during the COVID19 pandemic. PLoS One. 2020; 15(12):e0243525.
    View in: PubMed
    Score: 0.031
  3. The authors reply. Pediatr Crit Care Med. 2020 11; 21(11):1023.
    View in: PubMed
    Score: 0.030
  4. The authors reply. Pediatr Crit Care Med. 2020 08; 21(8):783-784.
    View in: PubMed
    Score: 0.030
  5. Generating randomized trial evidence to optimize treatment in the COVID-19 pandemic. CMAJ. 2020 Apr 14; 192(15):E405-E407.
    View in: PubMed
    Score: 0.029
  6. Key considerations on the potential impacts of the COVID-19 pandemic on antimicrobial resistance research and surveillance. Trans R Soc Trop Med Hyg. 2021 10 01; 115(10):1122-1129.
    View in: PubMed
    Score: 0.008
  7. Characteristics and outcomes of patients with COVID-19 admitted to hospital and intensive care in the first phase of the pandemic in Canada: a national cohort study. CMAJ Open. 2021 Jan-Mar; 9(1):E181-E188.
    View in: PubMed
    Score: 0.008
  8. Outcomes for patients with COVID-19 admitted to Australian intensive care units during the first four months of the pandemic. Med J Aust. 2021 01; 214(1):23-30.
    View in: PubMed
    Score: 0.008
  9. Coronavirus Disease 2019 in Critically Ill Children: A Narrative Review of the Literature. Pediatr Crit Care Med. 2020 07; 21(7):662-666.
    View in: PubMed
    Score: 0.007
  10. Care for Critically Ill Patients With COVID-19. JAMA. 2020 Apr 21; 323(15):1499-1500.
    View in: PubMed
    Score: 0.007
  11. Clinical research networks and assessing pandemic severity. Lancet Glob Health. 2019 01; 7(1):e33.
    View in: PubMed
    Score: 0.007
  12. Post-COVID-19 multisystem inflammatory syndrome in children. Can Fam Physician. 2021 Aug; 67(8):594-596.
    View in: PubMed
    Score: 0.002
  13. Risk of dispersion or aerosol generation and infection transmission with nasopharyngeal and oropharyngeal swabs for detection of COVID-19: a systematic review. BMJ Open. 2021 03 17; 11(3):e040616.
    View in: PubMed
    Score: 0.002
  14. Antimicrobial resistance research in a post-pandemic world: Insights on antimicrobial resistance research in the COVID-19 pandemic. J Glob Antimicrob Resist. 2021 06; 25:5-7.
    View in: PubMed
    Score: 0.002
  15. Study protocol for a multicentre, prospective cohort study of the association of angiotensin II type 1 receptor blockers on outcomes of coronavirus infection. BMJ Open. 2020 12 07; 10(12):e040768.
    View in: PubMed
    Score: 0.002
  16. Leveraging a Cloud-Based Critical Care Registry for COVID-19 Pandemic Surveillance and Research in Low- and Middle-Income Countries. JMIR Public Health Surveill. 2020 11 23; 6(4):e21939.
    View in: PubMed
    Score: 0.002
  17. CMAJ. 2020 10 26; 192(43):E1323-E1333.
    View in: PubMed
    Score: 0.002
  18. A national cross-sectional survey of public perceptions of the COVID-19 pandemic: Self-reported beliefs, knowledge, and behaviors. PLoS One. 2020; 15(10):e0241259.
    View in: PubMed
    Score: 0.002
  19. Association Between Administration of Systemic Corticosteroids and Mortality Among Critically Ill Patients With COVID-19: A Meta-analysis. JAMA. 2020 10 06; 324(13):1330-1341.
    View in: PubMed
    Score: 0.002
  20. Effect of Hydrocortisone on Mortality and Organ Support in Patients With Severe COVID-19: The REMAP-CAP COVID-19 Corticosteroid Domain Randomized Clinical Trial. JAMA. 2020 10 06; 324(13):1317-1329.
    View in: PubMed
    Score: 0.002
  21. Corticosteroid therapy for critically ill patients with COVID-19: A structured summary of a study protocol for a prospective meta-analysis of randomized trials. Trials. 2020 Aug 24; 21(1):734.
    View in: PubMed
    Score: 0.002
  22. Anti-Thrombotic Therapy to Ameliorate Complications of COVID-19 (ATTACC): Study design and methodology for an international, adaptive Bayesian randomized controlled trial. Clin Trials. 2020 10; 17(5):491-500.
    View in: PubMed
    Score: 0.002
  23. Drug treatments for covid-19: living systematic review and network meta-analysis. BMJ. 2020 07 30; 370:m2980.
    View in: PubMed
    Score: 0.002
  24. Remdesivir for severe covid-19: a clinical practice guideline. BMJ. 2020 07 30; 370:m2924.
    View in: PubMed
    Score: 0.002
  25. The REMAP-CAP (Randomized Embedded Multifactorial Adaptive Platform for Community-acquired Pneumonia) Study. Rationale and Design. Ann Am Thorac Soc. 2020 07; 17(7):879-891.
    View in: PubMed
    Score: 0.002
  26. High-flow nasal cannula for acute hypoxemic respiratory failure in patients with COVID-19: systematic reviews of effectiveness and its risks of aerosolization, dispersion, and infection transmission. Can J Anaesth. 2020 09; 67(9):1217-1248.
    View in: PubMed
    Score: 0.002
  27. Treatment of patients with nonsevere and severe coronavirus disease 2019: an evidence-based guideline. CMAJ. 2020 05 19; 192(20):E536-E545.
    View in: PubMed
    Score: 0.002
  28. COVID-19: a novel coronavirus and a novel challenge for critical care. Intensive Care Med. 2020 05; 46(5):833-836.
    View in: PubMed
    Score: 0.002
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.